Company Filing History:
Years Active: 2010-2014
Title: Innovations by Joel Gatlin
Introduction
Joel Gatlin is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of medical research, particularly in the area of atherosclerosis and neurodegenerative diseases. With a total of 2 patents to his name, Gatlin's work focuses on developing therapeutic agents that can modulate critical biological processes.
Latest Patents
Gatlin's latest patents include innovative methods for screening compounds that reduce atherogenesis. This invention relates to the use of a G protein-coupled receptor (GPCR) to identify candidate compounds that can act as modulators of atherogenesis. The GPCR in question may couple to Gi and is human in certain embodiments. The agonists derived from this invention are intended for the prevention or treatment of atherosclerosis and related diseases, such as coronary artery disease and myocardial infarction.
Another notable patent by Gatlin involves human G protein-coupled receptors and their modulators for treating cell death-related disorders. This invention outlines methods for identifying candidate compounds that modulate GPCRs, particularly those expressed by neuronal or muscle cells. The agonists developed from this research are aimed at treating neurodegenerative diseases, including Alzheimer's and Parkinson's diseases, as well as conditions like peripheral neuropathy and ischemic heart disease.
Career Highlights
Joel Gatlin is currently employed at Arena Pharmaceuticals, Inc., where he continues to advance his research in pharmacology and therapeutic development. His work has the potential to significantly impact the treatment of various diseases, improving the quality of life for many patients.
Collaborations
Gatlin has collaborated with notable colleagues, including David J Unett and Yaron Hakak. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Joel Gatlin's contributions to medical research through his patents demonstrate his commitment to advancing healthcare solutions. His innovative approaches to addressing complex health issues highlight the importance of continued research and development in the field.